Canada tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around-0.7% during the forecast period. More than 1,600 new cases of active TB are reported in Canada every year. About 90% of these cases affect 2 main populations in which 70% of cases occur among foreign-born individuals, while 20% of cases occur among Canadian-born Indigenous Peoples. More than 1,796 tuberculosis incidences were reported in 2017. As tuberculosis is a noticeable disease, it must be legally reportable to the provincial/territorial governments in all provinces and territories in the country. Cases of active TB are generally reported to provincial or territorial departments of health. However, there are no laws in place requiring these territories to report cases or outcome data to the federal government. They may voluntarily submit their surveillance data. The federal government uses this data to produce national surveillance reports.

Request a Free Sample of our Canada Tuberculosis Diagnosis and Treatment Market: https://www.omrglobal.com/request-sample/canada-tuberculosis-diagnosis-treatment-market

With the motive to eliminate TB in the country, The Canadian Tuberculosis Reporting System (CTBRS) has been used in the country. Through this, provincial and territorial tuberculosis control programs participate in the CTBRS national surveillance system and report to the Centre for Communicable Diseases and Infection Control (CCDIC) and Public Health Agency of Canada (PHAC) about the all new and re-treatment cases of active tuberculosis that meet the Canadian case definition. This surveillance and prevalence of TB incidence cases shows the demand of diagnosis tools as well as drugs in the country and reflects its major role in motivating the market

A full Report of Canada Tuberculosis Diagnosis and Treatment Market is Available at: https://www.omrglobal.com/industry-reports/canada-tuberculosis-diagnosis-treatment-market

Canada tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.

Canada Tuberculosis Diagnosis and Treatment Market Segmentation

By Drugs Type

• First Line Drugs
• Second Line Drugs

By Diagnosis

• Laboratory Testing
• Nucleic Acid Amplification Test
• Mantoux Test
• Radiography
• Drug Susceptibility Testing

Company Profiles

• Abbott Laboratories
• Akonni Biosystems, Inc.,
• Alere Inc.
• Becton, Dickinson and Co.
• Cepheid, Inc
• Hologic, Inc.
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/canada-tuberculosis-diagnosis-treatment-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404